SREBF2 and breast carcinoma: These effects were not limited to HepG2 cells since the inactivation of Fbw7 in MCF7 cells, a human breast cancer cell line, also stabilized nuclear SREBP1 and reduced the cleavage of SREBP2 (Figure S2).